Načítá se...
A Rare Case of Ticagrelor-Induced Profound Isolated Thrombocytopenia
Ticagrelor is a new oral antiplatelet drug that has a strong proven benefit of reducing the rate of death from cardiovascular causes, myocardial infarction, and stroke compared with clopidogrel. Ticagrelor is widely used by patients with acute coronary syndrome. However, profound thrombocytopenia ha...
Uloženo v:
| Vydáno v: | Acta Cardiol Sin |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taiwan Society of Cardiology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5611356/ https://ncbi.nlm.nih.gov/pubmed/28959112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6515/ACS20161021C |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|